Gefigen-250
| Packed: |
250 mg / 30 Tablets |
|---|---|
| Manufacturer: |
Hetero Labs Limited |
| Active ingredient: |
Gefitinib Tablets IP 250 mg |
Locally advanced or non-small cell metastatic lung cancer with activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor in the first line of therapy.
Locally advanced or non-small cell metastatic lung cancer that is refractory to chemotherapy regimens containing platinum derivatives.
